The Wnt pathway controls cell fate during embryonic development. It also persists as a key regulator of homeostasis in adult self-renewing tissues. In these tissues, mutational deregulation of the Wnt cascade is closely associated with malignant transformation. The intestinal epithelium represents the best-understood example for the closely linked roles of Wnt signaling in homeostatic self-renewal and malignant transformation. In this review, we outline current understanding of the physiological role of Wnt signaling in intestinal biology. From this perspective, we then describe how mutational subversion of the Wnt cascade leads to colorectal cancer.
Development and homeostasis in all multicellular organisms depend on a complex interplay between processes involved in cell proliferation, migration, differentiation, adhesion, and death. This diverse array of cellular responses is in large part coordinated by a relatively small number of intercellular signals, examples of which include the BMP, TGF, Notch, Hh, and Wnt pathways. One of the major developments in recent years has been the realization that the signaling pathways triggered by these factors are very often deregulated in pathological conditions (Massague et al. 2000; Polakis 2000; Waite and Eng 2003; Bijlsma et al. 2004; Lefort and Dotto 2004; Moon et al. 2004 ). This notion is particularly well illustrated by the role of the Wnt pathway in the intestinal epithelium. The relevance of Wnt signaling to intestinal biology was established, unknowingly at the time, more than 10 years ago when the tumor suppressor gene Adenomatous polyposis coli (APC) was found mutated in a large number of hereditary and sporadic cases of CRC (Groden et al. 1991; Kinzler et al. 1991; Nagase and Nakamura 1993) . Subsequently, combined work from several laboratories led to the finding that inactivation of APC in CRC cells results in constitutively active Wnt signaling (Rubinfeld et al. 1993; Korinek et al. 1997; Morin et al. 1997) . Since these early findings, a much richer picture has emerged. It is now recognized that Wnt signaling not only drives tumorigenesis but is also required at different stages of gut development, as well as during adult epithelial homeostasis. Our approach in this review will be to dissect the different functions attributed to Wnt signaling at these various time points. First, we shall begin by introducing some of the components of the pathway most relevant to our discussion.
A short summary of the Wnt pathway
Wnts and their downstream effectors were originally discovered in Drosophila and subsequently shown to be conserved in all metazoans (Wodarz and Nusse 1998) . Genetic and biochemical data taken from these models have, to date, identified >50 proteins directly involved in transducing Wnt signals (see The Wnt Homepage, http://www.stanford.edu/∼rnusse/wntwindow.html). How these proteins interact with one another to stimulate various biological responses has been an area of intense investigation.
Wnt genes, of which there are 19 in man and mice, encode for cysteine-rich glycoproteins. Production of biologically active Wnts depends on palmitoylation of a conserved cysteine residue (Willert et al. 2003) . This process may be mediated by Porcupine/MOM1; however, direct proof for this has not yet been provided (van den Heuvel et al. 1993; Kadowaki et al. 1996; Rocheleau et al. 1997) . Once released into the extracellular milieu, Wnts interact with secreted proteins such as SFRPs and WIF (Kawano and Kypta 2003) . In general, these factors are thought to function as inhibitors by sequestering Wnts and preventing their interaction with membrane-bound receptors. Other interaction partners include membraneanchored heparan sulfate proteoglycans (HSPGs). In Drosophila, the HSPG Dally acts as a positive regulator of Wnt activity, but its precise biochemical function is unknown (Tsuda et al. 1999) .
Wnts activate responding cells by interacting with the seven-span transmembrane protein Frizzled (Fz) and the single-span transmembrane protein LRP (Bhanot et al. 1996; Pinson et al. 2000; Tamai et al. 2000; Wehrli et al. 2000) . Two functional complexes involving these proteins have been described. Wnts may simultaneously bind to Fz and LRP. This represents the initial step in the so-called canonical pathway, which leads to the formation of nuclear Tcf/␤-catenin complexes. Alternatively, when LRP is not expressed or down-modulated through secreted factors such as Dickkopfs (Bafico et al. 2001) , Wnts may nonetheless form a complex with Fz, triggering Tcf/␤-catenin-independent cellular responses such as increased calcium flux, repression of Tcf-mediated transcription, and cytoskeletal rearrangements. Collectively, these responses are often referred to as noncanonical signaling (Veeman et al. 2003) . As of yet, this aspect of Wnt signaling has not been analyzed in the gut. For this reason, noncanonical Wnt signaling will not be covered in this review.
The key component of the Wnt canonical cascade is the cytoplasmic protein ␤-catenin. In the absence of Wnts, the scaffolding proteins APC and Axin/Axin2 sequester ␤-catenin allowing casein kinase I (CKI) to phosphorylate the N terminus of ␤-catenin at Ser S45, a residue often mutated in cancers (Amit et al. 2002; Liu et al. 2002) . Subsequently, glycogen synthase kinase 3 ␤ (GSK3␤) is recruited to phosphorylate additional serine and threonine residues N-terminal to S45 (Rubinfeld et al. 1996) . Phosphorylated ␤-catenin is then recognized by the F-box-containing protein ␤-TrCP, which mediates ubiquitination and proteosomal degradation of ␤-catenin (Hart et al. 1999; Kitagawa et al. 1999; Winston et al. 1999) . Together, these proteins make up the so-called ␤-catenin destruction complex. As we shall see later, this complex plays a central role in the (de)regulation of intestinal homeostasis.
Under physiological conditions, continued destruction of ␤-catenin is interrupted following Wnt binding to Fz/ LRP. How the destruction complex senses Wnts at the cell surface is not fully understood. It has been assumed that the adapter protein Dsh through its association with Fz and the GSK3␤-binding protein, Frat, may participate in this process (Yost et al. 1998; Chen et al. 2003; Wong et al. 2003) . Note, however, that recent genetic evidence excludes an essential requirement for Frat in Wnt signaling, since mice with deletions in all three Frat family members develop entirely normally (van Amerongen et al. 2005) . In parallel, Wnts induce phosphorylation of the cytoplasmic tail of LRP, which allows docking of Axin to LRP (Tamai et al. 2004) . Recruitment of Axin to the membrane is thought to disrupt the destruction complex, thereby releasing ␤-catenin. Lastly, it has been suggested that stabilization of ␤-catenin may be promoted by the protein phosphatase PP2A, which appears to dephosphorylate GSK3␤ substrates, including ␤-catenin (Yang et al. 2003) .
Once released from the destruction complex, ␤-catenin translocates to the nucleus, where it associates with the Tcf family of transcription factors (Tcf1, Lef, Tcf3, and Tcf4) (Waterman 2004) . Tcfs function by targeting ␤-catenin to specific DNA elements found in promoters and enhancers of target genes (Behrens et al. 1996; Molenaar et al. 1996) . In turn, ␤-catenin recruits a number of nuclear factors responsible for transactivating Tcf target genes. Two of these factors include the histone acetylase CBP/p300 and the SWI/SNF component BRG1 (Hecht et al. 2000; Takemaru and Moon 2000; Barker et al. 2001) . Activation of target genes also depends on the nuclear proteins Legless and Pygopus (Kramps et al. 2002; Parker et al. 2002; Thompson et al. 2002) . It has been proposed that Legless and Pygopus are involved in directly activating transcription, possibly by recruiting chromatin remodeling factors. Legless and Pygopus may also function by transporting ␤-catenin to the nucleus (Townsley et al. 2004 ). Finally it is worth noting that in the absence of nuclear ␤-catenin or when nuclear ␤-catenin is sequestered by factors such as ICAT and Chibby (Tago et al. 2000; Takemaru et al. 2003) , Tcfs associate with general transcriptional repressors such as Groucho (Cavallo et al. 1998; Roose et al. 1998 ). The latter silence target genes, in part, by recruiting histone deacetylases (HDACs), which render chromatin structure inaccessible to the basal transcriptional machinery. For an overview of the canonical Wnt pathway see Figure 1 .
Wnt signaling and the origin of intestinal epithelial cells
The intestinal epithelium originates from embryonic endoderm, which in turn stems from pluripotent epiblast cells at the onset of gastrulation (embryonic day 6.0 [E6.0] in mice). During this stage, epiblast cells committed to form definitive endoderm ingress through the primitive streak displacing visceral endoderm. The first endodermal cells to travel through the primitive streak populate the anterior end of the embryo, whereas endoderm leaving at later stages colonizes more posterior regions. From E7.5 to E9.5, the endodermal lining covering the mesoderm and ectoderm undergoes a series of invaginations initiated at the anterior and posterior ends of the embryo, resulting in the formation of a proper gut tube (Fig. 2) . At this stage, the primitive gut is composed of a uniform layer of cuboidal endodermal cells surrounded by splanchnic mesoderm. The intestine along with the other organs derived from endoderm only become morphologically evident during a patterning phase (E9.5-E14.5) in which the primordial gut is subdivided and reshaped along the anterior-posterior axis (Fig. 2) . For a thorough treatment of gut development see Wells and Melton (1999) and Roberts (2000) .
The earliest role attributed to Wnt signaling during gut development was initially uncovered in ascidian embryos, where ␤-catenin was found to be essential for endoderm formation (Imai et al. 2000) . Through gene targeting experiments, Kemler and colleagues (Lickert et al. 2002) showed that this function of ␤-catenin is evolutionarily conserved in mice. Ablation of ␤-catenin specifically in the node, notochord, and anterior primitive streak abrogated definitive endoderm formation. Moreover, analysis of chimeric embryos showed that ␤-catenin-mutant cells of the endodermal layer were unable to form endoderm but rather differentiated into precardiac mesoderm.
How ␤-catenin promotes definitive endoderm formation is unclear. Recent data have suggested that in endodermal cells, ␤-catenin may not necessarily act through Tcf factors. Indeed, Sinner et al. (2004) have proposed that in frogs, ␤-catenin drives the expression of endoderm-specific target genes by physically associating with Sox17, an HMG box transcription factor, related to Tcfs. Given that in zebrafish and mice Sox17 also plays a role in the formation of definitive endoderm (Alexander and Stainier 1999; Kanai-Azuma et al. 2002) , it will be interesting to test whether the Sox17/␤-catenin complex may represent a generalized mechanism for promoting endoderm specification. Another unanswered question raised by these findings regards the identity of the Wnt(s) stimulating ␤-catenin in the endoderm. In mice, Wnt3 is a possible candidate, since in Wnt3-mutant embryos, the epiblast remains undifferentiated while the primitive streak does not form. Moreover, the expression of both mesodermal and definitive endodermal markers is abolished (Liu et al. 1999) .
We have recently shown that Wnt signaling is required for gut tube formation (Gregorieff et al. 2004) . During this stage (E8.5), in situ hybridization analysis revealed overlapping expression of Tcf4 and Tcf1in the hindgut. Simultaneous disruption of both genes led to severe defects in the formation of the hindgut and associated loss of expression of endodermal markers. This phenotype implies the existence of a Wnt source at the posterior end of the embryo, which would promote morphogenesis of the hindgut. A similar mechanism is utilized to drive posterior paraxial mesoderm and somite formation. In this case, Wnt3a expression in the presomitic mesoderm of the tailbud activates Lef and Tcf1 (Galceran et al. 1999) . Anterior tube formation may also depend on the activity of Wnt signaling components. Analysis of APC hypomorphic mutant mice (APC neoR ) has shown that expression of APC in the endoderm is required for the involuting movements, which generate the foregut pocket ( Fig. 2, AIP ; Ishikawa et al. 2003) . The foregut defects in APC hypomorphs may result from the increased ␤-catenin/Tcf transcriptional activity in endodermal cells or may be ascribed to an alternative role for APC in cell migration.
Our analysis of Tcf4/Tcf1 mutant embryos at later stages also revealed malformations of the gastrointestinal tract consistent with both factors playing a role in patterning the gut (Gregorieff et al. 2004 ). As could be expected from the early defects in hindgut formation, the intestine of Tcf4
−/− embryos is severely truncated. However, closer inspection uncovered anterior transformations at the stomach-duodenal junction. Expression analysis using specific markers of stomach and intestine revealed duplications of the stomach, suggesting that Tcf4 and Tcf1 promote an "intestinal" fate within the primitive gut, and in their absence more anterior regions of the gut are expanded. Evidence supporting this interpretation was recently provided by Hogan and coworkers (Okubo and Hogan 2004) , who showed that when a constitutively active form of ␤-catenin is misexpressed in the lung endoderm, these cells turn on genes normally restricted to the intestine, implying once again that Wnt signals instruct endodermal cells to become intestine as opposed to other endodermal lineages.
Wnt signaling and adult intestinal homeostasis
Once the basic structure of the intestinal tract is laid out, differentiation along the radial axis may take place (Figs. 2, 3) . During this process the epithelium of the small intestine is remodeled to form characteristic finger-like projections (villi) and deep invaginations termed crypts. Similar events take place in the colon, where crypts form but a flat surface epithelium exists instead of villi. These events coincide with the compartmentalization and cyto-differentiation of the epithelium. The intervillus regions of the fetal intestine, which are replaced by crypts in the first weeks after birth, are lined with highly proliferative progenitor cells. These transit-amplifying cells give rise to two differentiated cell lineages (i.e., the absorbtive enterocytes and secretory cells). The secretory lineage can be further subdivided into mucussecreting goblet cells, hormone-secreting enteroendocrine cells, and bactericidal Paneth cells. Maturation of progenitor cells coincides with upward migration. Upon reaching the tips of the villi or the surface epithelium of the colon, the differentiated cells undergo apoptosis and are shed into the lumen. One exception to this rule is the Paneth cell, which is generated from a progenitor migrating downward toward the crypt base. The self-renewing capacity of the intestine depends on the existence of stem cells (Marshman et al. 2002; Pinto and Clevers 2005) . Classical labeling experiments have shown that in the small intestine stem cells reside just above the Paneth cell compartment, while in the colon they occupy the first cell position at the crypt bottom.
There are now several lines of in vivo evidence that show that normal proliferation of the transit-amplifying cells is entirely dependent on continual stimulation of the Wnt pathway. First, removal of Tcf4, ␤-catenin, or overexpression of the Wnt inhibitor Dkk-1 results in a severe loss of proliferative epithelial cells in both the fetal and adult intestine (Korinek et al. 1998; Pinto et al. 2003; Ireland et al. 2004; Kuhnert et al. 2004) . Cell cycle arrest is also observed in CRC cell lines in which ␤-catenin/Tcf activity is blocked either through expression of dominant-negative Tcf4 or knockdown of ␤-catenin (van de Wetering et al. , 2003 . Consistent with these results, mutations in the negative regulator of Wnt signaling APC, or overexpression of oncogenic forms of ␤-catenin result in hyperproliferation of the epithelium (Nagase and Nakamura 1993; Oshima et al. 1995; Kinzler and Vogelstein 1996; Sansom et al. 2004 ). Lastly, progenitors located at the bottom of the crypts accumulate nuclear ␤-catenin, implying that these cells respond to Wnt stimulation . Although these studies confirm the strong link between Wnt signaling and maintenance of transit-amplifying cells, it should be noted that virtually no evidence exists to draw a similar link between Wnt signals and stem cells (Fig. 3) . Part of the difficulty in tackling this issue is related to our lack of reliable markers of intestinal stem cells. In addition to proliferation, we may also consider the accumulating evidence implying an additional function for Wnt signaling in driving the differentiation of secretory lineages. Indeed, blocking active Wnt signaling in vivo results in a reduction or absence of goblet, enteroendocrine, and Paneth cells, while enterocytes appear spared (Korinek et al. 1998; Pinto et al. 2003; Ireland et al. 2004) .
Supported by these findings, a model can be proposed whereby transit-amplifying cells responding to a source of Wnts at the crypt bottom proliferate and concomitantly commit themselves to the secretory lineage. As these progenitors move up the crypt and further away from the Wnt source, Tcf/␤-catenin activity is turned off, thus favoring cell cycle arrest and terminal differentiation. This simplistic view overlooks a number of issues. In our discussion below, we shall highlight four major questions: What is the genetic program regulated by Tcf/ ␤-catenin in crypt progenitors? Where and what is the Wnt source? How does Wnt signaling regulate secretory cell lineage commitment? And, finally, how is Wnt signaling turned off?
Tcf/␤-catenin target genes
Most studies aimed at identifying Tcf/␤-catenin target genes (for simplicity the term target gene here refers to either direct or indirect Wnt-responsive genes) in intestinal cells have made use of systems in which ␤-catenin is constitutively activated such as in CRC cell lines (see Table 1 for a selected list of Tcf target genes). Consequently, as we shall see later, the majority of Tcf/␤-catenin target genes have been associated with various .5 embryo, along with a schematic representation of the primitive gut. At E8.5 endodermal tube formation is initiated by folding (depicted by arrows) of the endodermal lining at the anterior and posterior ends creating anterior and caudal intestinal portals (AIP and CIP). The endodermal lining is stained with a probe recognizing Foxa1. At later stages (E9.5-E14.5), the primitive gut tube is patterned along the anteriorposterior axis. The expression of specific intestinal markers first appears in the hindgut at E9.0 (Maunoury et al. 1992; Braunstein et al. 2002) . The middle panel shows a whole mount preparation of the entire gastro-intestinal tract (E12.5) stained for the intestinal marker Villin. Villus formation and cyto differentiation (formation of enterocytes, goblet cells, enteroendocrine cells and Paneth cells) is initiated at E14.5. In the right panel, sections from the small intestine were stained for the proliferation marker Ki67. Mutations associated with the Wnt pathway affect gut development at various stages (see text). processes important for tumorigenesis (i.e., cellular proliferation, survival, and motility). Given that many of these genes are also expressed in normal crypt progenitor cells , efforts are now being undertaken, through classical loss-or gain-of-function experiments in mice, to test their function during intestinal development and homeostasis. So far, however, only a limited number Tcf/␤-catenin targets have been tested in vivo.
The proliferative effects of Wnt signaling on crypt progenitors have, for some time now, been linked to cell cycle regulators such as c-Myc and cyclin D1 (He et al. 1998; Shtutman et al. 1999; Tetsu and McCormick 1999) . Both factors are overexpressed in colorectal tumors, and blocking expression of either gene inhibits proliferation in CRC cell lines (Arber et al. 1997; van de Wetering et al. 2002; Wong and Pignatelli 2002) . However, cyclin D1 null mice do not appear to exhibit any abnormalities in the intestine, other than a modest reduction in the propensity to develop polyps when crossed with the APC min mice (Hulit et al. 2004 ). This observation suggests that other cyclin Ds may be more relevant downstream ␤-catenin/Tcf target genes. Along these lines, our own observations have shown that cyclin D2 is an early downstream Tcf4 target in the fetal gut (A. Gregorieff and H. Clevers, unpubl.) . Moreover, microarray studies have shown that cyclin D1 levels do not appear to be affected when conditionally deleting APC ). C-Myc has been confirmed as a Tcf/␤-catenin target in vivo Pinto et al. 2003) , although its precise function in normal epithelial cells remains to be clarified. In the bone marrow, recent evidence suggests that c-Myc promotes the release of hemopoietic stem cells from the stem cell niche by regulating the expression levels of adhesion molecules (Wilson et al. 1997 ). In the skin, ectopic expression of c-Myc diverts epidermal stem cells to a sebaceous gland fate at the expense of hair follicles (Braun et al. 2003) . Whether c-Myc performs similar functions in the intestine will need to be examined by a conditional knockout approach.
Another Tcf/␤-catenin target gene, which has been implicated in promoting proliferation is Id2 (Rockman et al. 2001; van de Wetering et al. 2002) . The Id proteins represent a family of naturally occurring inhibitors of basic helix-loop-helix transcription (bHLH) factors, and function in many circumstances to prevent differentiation (Ruzinova and Benezra 2003) . In particular, Id2 is highly abundant in several cancer types, and when forcibly expressed in colon cancer cell lines, Id2 has been shown to increase anchorage-independent survival (Rockman et al. 2001) . Recent in vivo evidence, on the contrary, suggests that Id2 may have a completely different role in crypt progenitor cells (Russell et al. 2004 ). In the Id2 knockout intestines, differentiation of endoderm is impaired during the late fetal stages (E18.5). Consequently the villi in several areas appear replaced by multilayered, undifferentiated endoderm. These areas of pseudostratified epithelium later develop into dysplastic and metaplastic tumors exhibiting high levels of nuclear ␤-catenin. Interestingly, these lesions also show a loss of Paneth cells and enteroendocrine cells and increased numbers of Goblet cells.
Expression profiling has also identified genes implicated in many other processes in addition to the control of proliferation and/or differentiation. The tyrosine kinase receptors EphB2 and EphB3 and their ligand ephrin B1 illustrate this point . Consistent with their well-known roles in cell sorting in various tissues, these receptor/ligands pairs are expressed in an 
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Cold Spring Harbor Laboratory Press on August 27, 2017 -Published by genesdev.cshlp.org Downloaded from inverse gradient along the crypt-villus axis, with EphB2 and EphB3 high in crypt cells and their ligand ephrin-B1 predominating in the villi. This expression pattern is tightly regulated both in vitro and in vivo by Tcf/␤-catenin. In vivo confirmation of the importance of these molecules came from the analysis of EphB2 −/− B3 −/− KO. In these mice, proliferative and differentiated cell populations intermingle. Furthermore, in EphB3 −/− mice, Paneth cells no longer home to the crypt bottom but rather scatter along crypts and villi. Thus, a Wnt signaling gradient controls cell positioning along the crypt-villus axis through regulation of EphB2 and EphB3 gene expression.
The functional characterization of Tcf/␤-catenin target genes will continue to be a major focus of interest for the coming years. We shall return to this issue in the context of colon carcinogenesis.
The Wnt source
The exact location or identity of the Wnts that drive proliferation is unclear. Nevertheless it is believed that mesenchymal cells or, more specifically, intestinal subepithelial myofibroblasts (ISEMFs), immediately adjacent to crypt epithelial cells, are a source of Wnts (Bienz and Clevers 2000; Madison et al. 2005 ). This notion is based in part on classic coculture experiments, which have shown that these cells are able to simulate proliferation of epithelial cells (Powell et al. 1999) We recently tested this hypothesis by screening all 19 Wnts for expression in the adult intestine (A. Gregorieff and H. Clevers, in prep.) . Through this approach we found several Wnts expressed in crypt epithelial cells, but so far none were detected in ISEMFs. Ablation of the Wnt (Fritsch et al. 2002) , which conceivably could activate Wnt gene expression in the epithelium. This idea however remains speculative. On a related issue, genetic evidence in mice has identified two transcription factors, FoxL1 and Nkx2.3, involved in regulating growth signals emanating from the mesenchyme (Kaestner et al. 1997; Pabst et al. 1999; Perreault et al. 2005) . Deletion of either gene in mesenchymal cells results in increased epithelial proliferation, suggesting that FoxL1 and Nkx2.3 normally play an inhibitory role. Kaestner and colleagues (Perreault et al. 2001 ) observed up-regulation of the HSPGs Syndecan1 and Perlecan in FoxL1 −/− mice. Although HSPGs have been implicated in stimulating Wnt signals (Tsuda et al. 1999; Perreault et al. 2001) , it remains to be tested whether these changes are a cause or an effect of the increased proliferation.
Cell lineage commitment
The disproportionate reduction in goblet, enteroendocrine, and Paneth cell numbers, resulting from the ablation of Wnt signals, suggests a definite role for Wnts in specifying secretory lineages. Recently, some general rules for cell lineage commitment in the intestine have been uncovered. Precursors of all three secretory cell types express the bHLH factor MATH1. Accordingly, MATH1 deficient mice lack goblet, enteroendocrine, and Paneth cells but do produce enterocytes (Yang et al. 2001) . The latter cells derive from progenitors expressing Hes1, based on the fact that Hes1 −/− intestines display increased numbers of secretory cells at the expense of enterocytes (Jensen et al. 2000) . Interestingly, Hes1 transcription is activated by Notch signaling in other biological models (Ohtsuka et al. 1999) , while Hes1 transcriptionally represses MATH1 expression (Jensen et al. 2000; Zheng et al. 2000) . Together these findings suggest a model whereby commitment toward the enterocyte lineage would be favored in cells with active Notch signaling, turning on Hes1 transcription. Inversely, in the absence of Notch signaling, MATH1 would be upregulated skewing the cells toward secretory lineages (Fig. 3B) .
Further commitment toward specific cell types depends on yet other transcription factors. For example, the activation of NGN3, BETA2, Pax4, and Pax6 is associated with enteroendocrine (sub)lineages (Schonhoff et al. 2004) , while differentiation of goblet cells is influenced by KLF4 (Katz et al. 2002) . Moreover, in ELF3 −/− mice differentiation of absorptive and goblet cells is impaired (Ng et al. 2002) .
The connection between Wnt signaling and any of these factors remains an open question. One putative link was suggested by the observation, as we have mentioned earlier, that ablation of the Wnt target gene and bHLH antagonist Id2 results in impaired production of secretory lineages (Russell et al. 2004) . It is plausible that Id2 may mediate these effects by directly antagonizing the activity of certain bHLH transcription factors such as MATH1. Alternatively, Wnt signals may directly activate the expression of genes involved in cell lineage commitment. Although no evidence for this exists so far, expression profiling of mouse models displaying impaired Wnt signaling suggests that the final stages of maturation of secretory lineages may depend on active Wnts signals. In particular, we and others find that the expression of Paneth cell markers, such as antimicrobial peptides (i.e., cryptdins and defensins), are directly stimulated by ␤-catenin/Tcf (Andreu et al. 2005; van Es et al. 2005 ).
Counteracting Wnt signaling
There are two nonmutually exclusive mechanisms that could explain how the stimulatory effects of the Wnt cascade are turned off in the intestine. In one scenario, activation of Wnt signals would gradually and passively dissipate as progenitors migrate up along the crypt-villi axis in sites where canonical Wnts are limiting. On the other hand, a more active mechanism may be utilized, involving "negative" cross-talk between the Wnt pathway and other signaling pathways. As we shall discuss below, the TGF␤ and BMP cascades are associated with growth inhibition in the gut and thus may represent examples of Wnt-counteracting pathways.
TGF␤ signaling components are localized in differentiated epithelial cells, where they have well-documented growth suppressive effects (Sancho et al. 2004) . Furthermore, in both man and mouse, benign adenomas acquire invasive properties following the acquisition of inactivating mutations in the TGF␤-RII receptor or the intracellular signaling components Smad2 and Smad4 (Markowitz et al. 1995; Eppert et al. 1996; Takagi et al. 1996) . Mice with germline mutations in Smad3 and the latent TGF␤-binding protein 4 (LTBP-4) also develop colorectal cancer (Zhu et al. 1998; Sterner-Kock et al. 2002) . Several groups have described mechanisms by which TGF␤ signals could antagonize Wnt signaling in the intestine. One possible route may involve the alternative TGF␤ effector and MAPKKK, TAKI. In Caenorhabditis elegans and mammalian cells, activation of TAK1 stimulates the activity of the MAPK NLK, which in turn, down-regulates Tcf Meneghini et al. 1999) . Alternatively, Sasaki et al. (2003) have shown that TGF␤ stimulation inhibits Tcf4/␤-catenin transactivation of cMyc via the ability of Smad3 to physically interact with ␤-catenin and thereby decouple Tcf4/␤-catenin complexes.
Similar inhibitory functions have been attributed to BMPs. BMP2 and BMP4 are expressed in mature epithelial cells and villus mesenchyme, respectively. Moreover, both factors appear to activate their downstream signaling components SMAD1, SMAD5, and SMAD8 in the differentiated epithelium (Haramis et al. 2004; Hardwick et al. 2004 ). Patients harboring mutations in BMP signaling components suffer from juvenile polyposis syndrome (JPS), which is characterized by the formation of hamartomatous polyps throughout the gastrointestinal tract (Howe et al. 2001 (Howe et al. , 2004 Zhou et al. 2001) . Similar polyps are formed in the stomach and duodenum of Smad4 heterozygous mice. Insight into how these defects occur was recently provided by the generation of transgenic mice expressing the BMP inhibitor Noggin in the intestinal epithelium (Haramis et al. 2004) and in mice in which the BMPR1A gene was conditionally deleted in the intestinal epithelium ). In both cases, these mice develop lesions equivalent to those found in JPS. At the earliest stages in the development of these lesions, BMP inhibition results in de novo crypt formation combined with increased numbers of proliferative cells in normally differentiated compartments of the villi. Based on these observations, it appears that BMP signaling may restrict ectopic Wnt-mediated proliferation in the differentiated epithelial cells and thereby confine crypt formation to regions immediately adjacent to the muscularis. How BMPs would antagonize Wnt signaling in the intestine still remains to be clarified. However, a tentative model has been proposed by He et al. (2004) , in which BMP4 somehow promotes PTEN activation in intestinal stem cells, which in turn would repress ␤-catenin/Tcf activity through the PI3 kinase-AKT pathway. These results await further confirmation.
Another class of signaling molecule, which may oppose the effects of Wnt signaling in the intestine are the Hedgehogs (Hh). The available evidence supporting such a role is somewhat conflicting. During chick and mouse development Sonic hedgehog (Shh) and Indian hedgehog (Ihh) play multiple roles in patterning of the gastrointestinal tract (Apelqvist et al. 1997; Litingtung et al. 1998; Ramalho-Santos et al. 2000; Sukegawa et al. 2000; Fukuda et al. 2003) . Both proteins have been implicated in the growth of upper-digestive tract tumors (Berman et al. 2003; Thayer et al. 2003) . Van den Brink et al. (2004) examined the role of Ihh signaling in the colonic epithelium. In the human colon, Ihh is uniquely expressed among nonproliferative cells of the surface epithelium. Accordingly, rats treated with cyclopamine, a smallmolecule inhibitor of Hh signaling, displayed defects in enterocyte differentiation and an increase in the number of cycling cells per crypt. These investigators also showed that Ihh signaling in vitro interferes directly with ␤-catenin/Tcf transcriptional activity ). More recently, ectopic epithelial proliferation was also reported in mice transgenically expressing the pan-Hh inhibitor HIP in the intestinal epithelium (Madison et al. 2005) . However, ablation of Hhs in mice by homologous recombination contradicts these results (Ramalho-Santos et al. 2000) . Ihh deficient mice display a loss of enteric neurons and as a result develop dilated colons reminiscent of Hirschprung's disease, while in the small intestine, the number of cycling epithelial cells is reduced. Shh mutant mice show intestinal metaplasia in the stomach and duodenal stenosis.
Wnt signaling in colorectal cancer
In humans, sporadic and hereditary forms of colorectal cancer develop along a well-defined sequence of histopathological changes (Fearon and Vogelstein 1990) . The earliest lesions occurring in the colonic epitheliumaberrant crypt foci (ACF)-are characterized by dysplastic or hyperplastic crypts. Subsequent expansion of the ACF generates larger adenomas, which in turn may progress to carcinoma in situ and invasive adenocarcinomas. Because these lesions are easily identifiable, researchers have been able to characterize the genetic alterations associated with each stage (Fearon and Vogelstein 1990; Sancho et al. 2004) . The earliest mutations identified in the adenoma-to-carcinoma sequence alter the function of components of the Wnt pathway. Mutations in APC are responsible for an inherited form of CRC, termed familial adenomatous polyposis (FAP) (Groden et al. 1991; Kinzler et al. 1991) . Moreover, the overwhelming majority (80%) of early adenomas from sporadic cases of CRC bear truncating mutations in APC (Nagase and Nakamura 1993) . Some of the remaining cases of CRC result from mutations in ␤-catenin, and Axin2 (Ilyas et al. 1997; Morin et al. 1997; Liu et al. 2000) . Below we shall discuss how activating mutations in the Wnt cascade confer upon cells a selective growth advantage, which allows for the initial expansion of the precancerous lesion.
Consequences of hyperactive Wnt signaling
The immediate consequences of mutations in APC and ␤-catenin are well understood. ␤-Catenin mutations disrupt the CK1/GSK3␤ phosphorylation sites at the N terminus of the protein (Ilyas et al. 1997; Morin et al. 1997) . Consequently, mutant ␤-catenin is no longer recognized by ␤-TrCP and becomes stabilized. In turn, mutant ␤-catenin is free to enter the nucleus and constitutively activate transcription through Tcfs. Equivalent effects result from APC inactivation. Truncation of APC removes repetitive elements within the protein responsible for binding to ␤-catenin and Axin (Nathke 2004) . As a result, GSK3␤ phosphorylation and subsequent degradation of ␤-catenin is severely impaired. Frameshift mutations in Axin2 eliminate its DIX domain required for homo-oligomerization. Although expression of mutant Axin2 in cells results in increased ␤-catenin accumulation, it is unknown how mutant Axin2 interferes with the destruction complex .
In addition to affecting the function of the destruction complex, mutations in APC have been proposed to disrupt its ability to regulate ␤-catenin function in the nucleus (Fabbro and Henderson 2003; Nathke 2004) . For example, APC contains both nuclear export and import signals, which allow it to act as a nuclear-cytoplasmic shuttle. Once in the nucleus APC promotes export of ␤-catenin and thereby deactivation of Tcf-mediated transcription, a property lost by mutation of APC (Henderson 2000; Rosin-Arbesfeld et al. 2003) . Alternatively, by associating with the transcriptional repressor CtBP, APC may also interfere with the formation of ␤-catenin/Tcf complexes (Hamada and Bienz 2004) . Whether these additional pathways regulating ␤-catenin activity play a significant role in neoplastic transformation remains to be determined.
How does constitutive ␤-catenin/Tcf transcriptional activity promote adenoma formation? As we first discussed in the context of homeostasis, the Wnt pathway normally promotes proliferation of progenitor cells. It is silenced when these cells exit the crypt compartment. In general terms, we may say that adenomas result from the unabated expansion of cells, which have adopted a crypt progenitor-phenotype. Consequently, the genes activated by aberrant ␤-catenin/Tcf activity in CRC cells simply reflect the normal genetic program of crypt progenitors . The identity and function of these target genes has been a hot topic in recent years. Today, the number of candidate ␤-catenin/ Tcf effector genes has exploded and includes genes that may intervene in the cell cycle (c-myc, cyclinD1), tumor cell migration (e.g., MMPs, Nr-CAM) (Wilson et al. 1997; Conacci-Sorrell et al. 2002) , survival (e.g., Survivin) (Zhang et al. 2001) , and growth (e.g., FGF18, Gastrin) (Koh et al. 2000; Shimokawa et al. 2003) , as well as angiogenesis (VEGF) (Easwaran et al. 2003 ) and prostaglandin signaling (e.g., COX-2, PPAR␦) (He et al. 1999; Hsi et al. 1999; Araki et al. 2003) . A complete description of all putative Tcf target genes identified so far would be well beyond the scope of this review. Instead we refer the reader to Table 1 , which highlights target genes that have been tested functionally in CRC cells.
Of particular relevance to this review is the observation that aberrant ␤-catenin/Tcf activity also leads to transcriptional up-regulation of components of the Wnt signaling pathway proper. In colon cancer cells, both Tcf1 and Lef are strongly up-regulated through direct activation by Tcf4. Genetic evidence in mice has shown that Tcf1 acts as tumor suppressor (Roose et al. 1999 ). Tcf1 knockout mice display a predisposition toward developing spontaneous intestinal adenomas, and polyp counts are greatly increased in APC min/+ mice lacking Tcf1. One untested hypothesis put forward to explain these results is the suggestion that in colon cancer cells Tcf4 promotes expression of dominant-negative isoforms of Tcf1, lacking the ␤-catenin interaction domain. As such, activation of Tcf1 expression would constitute a negative feedback loop involved in inhibiting high levels of ␤-catenin/Tcf activity. The effects of up-regulating Lef in tumor cells have not been tested in vivo. However, Lef is likely to play a positive role in tumorigenesis based on the observation that Tcf4 specifically activates transcription of full-length Lef isoforms capable of interacting with ␤-catenin (Hovanes et al. 2001 ). In addition, Lef has been shown to harbor distinct biochemical properties when compared to Tcf4. For instance, Lef, contrary to Tcf4, appears to be refractory to the inhibitory effects of a TGF␤-Smad3 pathway (Sasaki et al. 2003) .
Another ␤-catenin/Tcf target gene and Wnt signaling component relevant to cancer is Axin2. In normal cells, as part of a negative feedback mechanism, Axin2 is upregulated following Wnt stimulation (Jho et al. 2002; Leung et al. 2002; Lustig et al. 2002) . As we have described earlier, this apparently attenuates excessive Wnt stimulation since inactivating mutations in Axin2 promote tumorigenesis. Up-regulating Axin2 in adenomas may also serve to suppress the effects of aberrant ␤-catenin signaling. This idea is supported by the finding that overexpression of Axin in CRC cell lines bearing mutations in APC (but not ␤-catenin) down-regulates ␤-catenin levels (Hart et al. 1998) . The significance of these observations awaits further in vivo confirmation.
New players in Wnt pathway-driven colorectal cancer?
Given the predominant role of the Wnt pathway in CRC and many other types of cancer, several laboratories have shifted their attention on other Wnt signaling components in addition to the usual culprits such as APC and ␤-catenin. Recently, two groups have documented, in a high percentage of human colorectal adenomas and aberrant crypt foci, epigenetic silencing of the genes encoding for SFRPs (Caldwell et al. 2004; Suzuki et al. 2004 ). Suzuki et al. (2004) followed up on these initial observations by testing the impact of expressing SFRPs in CRC cell lines. Transfection of SFRP1, SFRP2, and SFRP5 in HCT116 and SW480 cells decreased ␤-catenin levels, and transcriptional activity and resulted in growth inhibition and apoptosis. However, in similar experiments performed by Bafico et al. (2004) , SFRP1 only had inhibitory effects on engineered HCT 116 cells containing a single wild-type ␤-catenin allele, whereas parental HCT116 cells with both wild-type and mutant alleles or HCT116 cells containing only a mutant allele were insensitive to SFRP1. Despite these discrepancies both groups show that HCT116 produce several Wnts and that treatment with SFRPs blocks autocrine Wnt-induced proliferation. Taking into account the results from Bafico et al. (2004) , it is more likely that silencing of SFRPs would only provide a growth advantage before mutations in APC and ␤-catenin have occurred. At later stages of tumorigenesis when cancer cells constitutively express high levels of ␤-catenin, disrupting Wnt function would most likely be inconsequential.
Concluding remarks
As we have highlighted in this article, the intestinal epithelium provides an attractive system to study how Wnt signaling regulates cellular growth and differentiation. Current evidence validates the Wnt cascade-in particular the ␤-catenin/Tcf4 complex-as a target for therapeutic strategies in the treatment of CRC. Breaching the interaction between ␤-catenin and Tcf in cancers using small organic molecules will be a hard nut to crack. Yet, some promising results have recently been reported by Shivdasani and colleagues (Lepourcelet et al. 2004) . The challenge in the long term will be to translate our increasing knowledge of the biochemical and functional features of the Wnt pathway into effective therapeutic strategies to combat cancer.
